Law, Che-Leung <br/><br/>
Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates.  [electronic resource] 

 -  Cancer research  Feb 2006 
 - 2328-37 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-05-2883  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD--biosynthesis<br/>Antineoplastic Agents--administration & dosage<br/>Apoptosis--drug effects<br/>CD27 Ligand<br/>Carcinoma, Renal Cell--drug therapy<br/>Cell Cycle--drug effects<br/>Humans<br/>Immunoconjugates--immunology<br/>Immunohistochemistry<br/>Kidney Neoplasms--drug therapy<br/>Lymphocyte Activation<br/>Membrane Proteins--biosynthesis<br/>Mice<br/>Mice, Nude<br/>Microtubules--drug effects<br/>Oligopeptides--administration & dosage<br/>Phenylalanine--analogs & derivatives<br/>RNA, Messenger--biosynthesis<br/>Tumor Necrosis Factors--biosynthesis<br/>Xenograft Model Antitumor Assays